Mint Medical
Mint Medical GmbH is a Heidelberg-based, private German software company that develops mint Lesion, a regulated (CE-marked, FDA 510(k)-cleared) radiological platform for AI-augmented structured reporting and clinical trial imaging. It serves university hospitals, pharma/CROs, and imaging biomarker researchers across EMEA and North America, and is part of the Snke ecosystem.
- Company typePrivate
- Founded2010
- HeadquartersHeidelberg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Mint Medical does
Mint Medical GmbH is a Heidelberg-based, private German software company founded in 2010 that develops mint Lesion, a regulated radiological software platform used for standardized and computer-assisted evaluation of imaging and clinical data. The platform provides AI-augmented guided structured reporting, dynamic implementation of oncology response criteria (RECIST, iRECIST, PI-RADS, PERCIST, BONE-RADS, Lung-RADS), and exports FHIR-compliant datasets with HIPAA and FDA CFR Part 11-capable audit trails. It is a Class II medical device (CE-marked since 2010, FDA 510(k)-cleared since 2011, certified to ISO 13485:2016 and EU MDR Annex IX) and serves diagnostic radiology departments in hospitals and university medical centers, pharmaceutical and contract research organizations running clinical trials, and academic imaging biomarker research groups. The portfolio includes the core mint Lesion platform, mint REX for radiology workflow, and mint Analytics for visual data analysis.
Mint Medical generates revenue primarily through enterprise licensing of mint Lesion (subscription or perpetual, quote-based) and complementary professional services including implementation, training, and customization billed on time-and-materials or fixed unit price terms. The go-to-market is enterprise field sales targeting large healthcare institutions and pharma/CRO clients through consultative demos, supplemented by presence at major radiology conferences (RSNA, ICIS, ESUR), direct website demo requests, and content marketing via LinkedIn, YouTube, and a Knowledge Hub. Customers include University Hospitals (Essen, Jena, Ulm, Cologne, Freiburg, Basel), Imperial College London, Sapienza University of Rome, Stanford, Royal Marsden NHS, and SLK Clinics Heilbronn. Following its March 2021 acquisition by Brainlab AG, Mint Medical became part of the Munich-based Snke healthcare technology ecosystem in June 2025 and has since pursued a platform strategy integrating third-party AI partners (Coreline Soft for lung cancer screening, ICR/Royal Marsden for bone disease AI), with a US office in Hamilton, NJ supporting North American sales.
Mint Medical firmographics
Firmographics- Name
- Mint Medical
- Legal name
- Mint Medical GmbH
- Website
- https://mint-medical.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mint Medical GmbH is a Heidelberg-based, private German software company that develops mint Lesion, a regulated (CE-marked, FDA 510(k)-cleared) radiological platform for AI-augmented structured reporting and clinical trial imaging. It serves university hospitals, pharma/CROs, and imaging biomarker researchers across EMEA and North America, and is part of the Snke ecosystem.
- Ownership category
- akta.pro rank
Mint Medical industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM)
- akta.pro secondary industry
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL)
Keywords
Where Mint Medical is headquartered
LocationHeadquarters
- HQ city
- Heidelberg
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Mint Medical business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing (mint Lesion): Mint Medical generates revenue through licensing of its mint Lesion software platform, which is sold as a configurable solution for diagnostic radiology, clinical trials, and imaging biomarker research. The software supports subscription or perpetual licensing models based on customer needs and deployment scope.
- Professional Services: Services including implementation, training, and customization are invoiced on a time-and-materials basis or at fixed unit prices. Travel and other expenses are billed additionally.
- Project Services: Project-based work services invoiced at unit prices or on time-and-materials basis after completion and acceptance of services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing for large healthcare institutions and pharma/CRO clients |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Mint Medical product offering
Product offeringCore offering
Mint Medical develops and licenses the mint Lesion software platform, an AI-augmented radiological image reading and reporting solution for diagnostic radiology, clinical trials, and imaging biomarker research. The platform provides guided structured reporting, automated response criteria compliance (e.g., RECIST, iRECIST, PI-RADS), longitudinal multi-site reading, and FHIR-compliant data export with HIPAA and FDA CFR Part 11-capable audit trails. Companion offerings mint REX and mint Analytics extend the platform with additional radiology workflow and visual analytics capabilities.
Product overview
Mint Medical develops and markets the leading radiological software solution mint Lesion, a platform that provides AI-powered structured reporting, guided assessment, and data-driven analytics. The product portfolio consists of the core mint Lesion platform complemented by specialized modules for Clinical Routine (diagnostic radiology with TNM, PI-RADS, RECIST support), Clinical Trials (phases I-III with automated response criteria), Imaging Biomarker Research, and Pharma/CRO applications. mint Lesion is used worldwide by healthcare providers, academic medical centers, and clinical research organizations. The platform integrates AI including Deep Learning and knowledge-based models, supports ontologies like RadLex, SNOMED, and CDISC SDTM, and generates FHIR-compliant datasets with audit trails compliant with HIPAA and FDA CFR Part 11. The companion product mint REX provides additional radiological workflow capabilities, while mint Analytics adds visual data analysis including volumetrics and radiomics.
Differentiator
Problem solved
Functional benefit
Brands
- mint Lesion: Radiological software solution for standardized and computer-assisted evaluation of radiological and clinical data, including AI-powered structured reporting, guided assessment, and data-driven analytics
- mint REX
- mint Analytics
Products and services
- mint Lesion The core radiological software platform for standardized, computer-assisted evaluation of radiological and clinical data. mint Lesion provides AI-powered structured reporting, guided assessment, and data-driven analytics for diagnostic radiology, clinical trials, and imaging biomarker research. It supports TNM staging, PI-RADS, RECIST, iRECIST, PERCIST, BONE-RADS, Lung-RADS, and other standardized assessment criteria, with FHIR-compliant data export and HIPAA/FDA CFR Part 11-capable audit trails. Used by university hospitals, clinics, radiology practices, academic centers, and pharma/CROs.
- mint REX Radiological software solution for structured reporting and workflow management in radiology departments, complementing the mint Lesion platform as an additional offering from Mint Medical.
- mint Analytics Visual data analytics software integrated with mint Lesion, providing advanced analytics capabilities including volumetrics, radiomics feature extraction, and tumor growth rate analysis for longitudinal radiological research and clinical trial imaging data review.
Quantifiable outcome
- mint Lesion generates machine-readable data in a semantic data model with HIPAA- and FDA CFR Part 11-capable audit trail for clinical trials phases I to III
- +2 more outcomes
Companies that use Mint Medical
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles4 records
Mint Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature6 records
Mint Medical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Coreline SoftcoreStrategic partnership to integrate Coreline Soft's AVIEW AI imaging platform with Mint Medical's mint Lesion structured reporting system for AI-enabled lung cancer screening workflows. The integration supports pulmonary nodule detection, structured reporting, longitudinal tracking, and multi-site reading management. Initially focused on Germany following the April 2026 introduction of LDCT-based lung cancer screening into statutory health insurance reimbursement, with plans to scale across international markets.
- SnkecoreSince June 2025, Mint Medical is part of Snke, a healthcare technology ecosystem. Snke drives digital transformation of healthcare from Munich with innovative solutions based on AI, Big Data, and scalable technologies. Mint Medical maintains its headquarters in Heidelberg while benefiting from the Snke ecosystem for career opportunities and cross-company collaboration.
- The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation TrustcoreLicensing agreement for integration of AI-powered software developed by ICR and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma. The partnership represents Mint Medical's strategy to integrate validated clinical AI algorithms into its platform.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Mint Medical competitors and assessment
Company assessmentBroad incumbents
- Brainlab: Former parent company of Mint Medical and a major incumbent in surgery, radiotherapy, and imaging software. Overlapping customer base in hospitals and radiology, with broader portfolio of clinical software products.
- Philips (IntelliSpace): Global health technology incumbent with IntelliSpace radiology and clinical trial imaging offerings. Competes broadly in the same hospital and clinical research accounts mint Lesion serves.
- GE HealthCare: Major imaging equipment and software incumbent with Edison AI platform and integrated radiology reporting. Comparable as a broad enterprise imaging IT vendor whose structured reporting and AI capabilities overlap with mint Lesion.
- Siemens Healthineers (AI-Rad Companion): Global medical imaging and diagnostics major with AI-Rad Companion and integrated reading workflow offerings. Competes broadly with mint Lesion via bundled PACS, reporting, and AI features inside dominant enterprise imaging installs.
- ICON plc (Medical Imaging): Large global CRO with a dedicated Medical Imaging division offering centralized imaging review and analysis for clinical trials. Comparable as a scaled, broad-spectrum provider of imaging services and software to pharma sponsors.
Emerging players
- Lunit: Public medical imaging AI company focused on oncology detection and biomarker analysis. Competes with portions of mint Lesion's AI-augmented diagnostic offering, particularly in lung and breast imaging AI.
Direct peers
- Perspectum: Provider of medical image analysis software for quantitative assessment in clinical trials and clinical routine. Comparable as a regulated imaging software vendor selling into academic medical centers, pharma, and CROs.
- RaySearch Laboratories: Public Swedish developer of treatment planning and oncology workflow software used in radiation therapy and radiology. Directly comparable to Mint Medical as a specialized, regulated software vendor serving oncology clinical workflows, university hospitals, and clinical trial imaging.
- Quibim: Medical imaging AI and radiomics platform targeting oncology and clinical research use cases. Competes with mint Lesion for biomarker research and pharma imaging budgets with a comparable AI-augmented, structured-data proposition.
- Median Technologies: Imaging biomarker and clinical trial imaging software vendor focused on oncology. Closely comparable to mint Lesion's clinical trial imaging offering, serving pharma and CRO clients with standardized, regulatory-grade imaging endpoints.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mint Medical social profiles
Digital presenceMint Medical compliance and trust
Trust signalCompliance4 records
Mint Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mint Medical leadership team
Management profileNumber of profiles
Profiles7 records
Mint Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mint Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mint Medical
What does Mint Medical do?
Mint Medical develops and licenses the mint Lesion software platform, an AI-augmented radiological image reading and reporting solution for diagnostic radiology, clinical trials, and imaging biomarker research. The platform provides guided structured reporting, automated response criteria compliance (e.g., RECIST, iRECIST, PI-RADS), longitudinal multi-site reading, and FHIR-compliant data export with HIPAA and FDA CFR Part 11-capable audit trails. Companion offerings mint REX and mint Analytics extend the platform with additional radiology workflow and visual analytics capabilities.
Is Mint Medical a public or private company?
Mint Medical is a private company. It is classified as corporate owned and is currently operating.
When was Mint Medical founded?
Mint Medical was founded in 2010. It employs 11 to 50 people.
Where is Mint Medical based?
Mint Medical is headquartered in Heidelberg, Germany, in the Europe region.
How does Mint Medical make money?
Three revenue lines are on record. Software Licensing (mint Lesion) is the primary driver. The others are professional Services and project Services.
Who are Mint Medical's main competitors?
Broad incumbents on record are Brainlab, Philips (IntelliSpace), GE HealthCare, Siemens Healthineers (AI-Rad Companion) and ICON plc (Medical Imaging). Lunit is listed as an emerging player. Direct peers are Perspectum, RaySearch Laboratories, Quibim and Median Technologies.
Does Mint Medical have an API?
No public API is recorded for Mint Medical.
What industry is Mint Medical in?
Mint Medical's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive), with a secondary code of HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management). Its NAICS code is 334510 and its SIC code is 3845.